GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Change In Payables And Accrued Expense

Kimia Biosciences (BOM:530313) Change In Payables And Accrued Expense : ₹0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Change In Payables And Accrued Expense?

Kimia Biosciences's Change In Payables And Accrued Expense for the quarter that ended in . 20 was ₹0.00 Mil. It means Kimia Biosciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

Kimia Biosciences's Change In Payables And Accrued Expense for the fiscal year that ended in . 20 was ₹0.00 Mil. It means Kimia Biosciences's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .


Kimia Biosciences Change In Payables And Accrued Expense Historical Data

The historical data trend for Kimia Biosciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Change In Payables And Accrued Expense Chart

Kimia Biosciences Annual Data
Trend
Change In Payables And Accrued Expense

Kimia Biosciences Semi-Annual Data
Change In Payables And Accrued Expense

Kimia Biosciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kimia Biosciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences Business Description

Industry
Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences Headlines

No Headlines